Phenotypic analysis of receptor-ligand pairs on B-cells in B-chronic lymphocytic leukemia

Leukemia and Lymphoma

Volumn 25, Issue 3-4, 1997, Pages 301-311

  Gagro, Alenka ^a   Dašić, Gorana ^a   Sabioncello, Ante ^a   Rabatić, Sabina ^a   Reckzeh, Barbara ^b   Havemann, Klaus ^b   Kardum, Ika ^c   Jakšić, Branimir ^c   Vitale, Branko ^d  

^a Institute of Immunology   (Croatia)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c University of Zagreb   (Croatia)

^d RUDER BO KOVI INSTITUTE   (Croatia)

Author keywords

B cell; B CLL; CD21; CD23; CD5; CD72; Chronic lymphocytic leukemia; Phenotypic analysis; Receptor ligand pairs; Three color immunofluorescence analysis

Indexed keywords

CD23 ANTIGEN; CD5 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR; ONCOPROTEIN;

ADULT; AGED; ARTICLE; B CELL LEUKEMIA; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; MALE; PHENOTYPE; PRIORITY JOURNAL;

EID: 0030961298     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.3109/10428199709114169     Document Type: Article

References (33)

1. Vitale, B., Kušić, B., Antica, M., Poljak, Lj., Gagro, A., Rabatić, S. and Jakšić, S. (1995) Chronic lymphocytic leukemia (CLL) a paradigm for developmental imbalance in B-cell and T-cell communication, Periodicum biologorum, 97. 273-80.
2. Dighiero, G., Travade, P., Chevret, S., Fenaux, P., Chastang, C. and Binet, J. L. (1991) B-cell chronic lymphocytic leukemia: present status and future directions. French Cooperative Group on CLL, Blood, 78, 1901-14.
3. Caligaris-Capio, F. (1996) B-chronic lymphocytic leukemia: a malignancy of anti-self B cells, Blood, 87, 2615-20.
4. Van de Velde, H., von Hoegen, I., Luo, W., Parnes, J. R and Thielemans, K. (1991) The B-cell surface protein CD72/Lyb- 2 is the ligand for CD5, Nature, 351, 662-4.
5. Burrows, P. D. and Cooper, M D (1993) B-cell development in man. Current Opinion in Immunology, 5, 201-6.
6. Gordon, J. (1994) B-cell signalling via the C-type lectins CD23 and CD72, Immunology Today, 15, 411-7.
7. Garand, R., Robillard, N. and Bataille, R. (1994) CD72 is constantly expressed in chronic lymphocytic leukemia and other B-cells lymphoproliferative disorders. Leukemia Research, 18, 651-2.
8. Delespesse, G., Suter, U., Mossalayi, D., Bettler, B., Sarfati, M., Hofstetter, H., Kilcherr, E., Debre, P. and Dalloul, A. (1991) Expression, structure and function of the CD23 antigen, Advances in Immunology, 49, 149-91.
9. Aubry, J. P., Pochon, S., Graber, P., Jansen, K U. and Bonnefoy, J. Y. (1992) CD21 is a ligand for CD23 and regulates IgE production, Nature, 358, 505-7.
10. Björck, P., Elenström-Magnusson, C., Rósen, A., Severinson, E. and Paulie, S. (1993) CD23 and CD21 function as adhesion molecules in homotypic aggregation of human B lymphocytes, European Journal of Immunology, 23, 1771-5.
11. Swendeman, S. and Thorley-Lawson, D. A. (1987) The activation antigen BLAST-2, when shed, is an autocrine BCGF for normal and transformed B cells, EMBO Journal, 6, 1637-42.
12. Sarfati, M. (1994) CD23 and chronic lymphocytic leukemia, Blood Cells, 19, 591-6.
13. Reinisch, W., Willheim, M., Hilgarth, M., Gashé, C., Mader, R., Szepfalusi, S., Steger, G., Berger, R., Lechner, K., Boltz-Nitulescu, G and Schwarzmeier, J. D (1994) Soluble CD23 reliably reflects disease activity in B-cell chronic lymphocytic leukemia. Journal of Clinical Oncology, 12, 2146-52.
14. Bennet, J. M., Catovsky, D., Daniel, M. T., Flandrin, G., Galton, D. A. G., Gralnick, H. R. and Sultan, C. (1989) The French-American-British (FAB) Cooperative Group: Proposals for the classification of chronic (mature) B and T lymphoid malignancies, Journal of Clinical Pathology, 42, 567-73.
15. Nunez, G., London, L., Hockenbery, D., Alexander, M., McKearn, J. P. and Korsmeyer, S. J. et al. (1990) Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived hemopoietic cell lines. Journal of Immunology, 144, 3603-10.
16. Melo, J. V., Catovsky, D., Gregory, W. M. and Galton, D. A. G. (1987) The relationship between chronic lymphocytic leukaemia and prolymphocytic leukaemia, British Journal of Haematology, 65, 23-9.
17. Orfao, A., Gonzales, M., San Miguel, J. F., Rios, A., Camzo, A. C., Hernandez, J., Maricato, M. L. and Borrasca, A. L. (1989) B-cell chronic lymphocytic leukaemia: Prognostic value of the immunophenotype and the clinico-haematological features, American Journal of Hematology, 31, 26-31.
18. Geisler, C H., Larsen, J. K., Hansen, N. E., Hansen, M. M., Chnstensen, B, E., Lund, B., Nielsen, H., Plesner, T., Thorling, K., Andersen, E. and Andersen, P. K. (1991) Prognostic importance of flow cytometric immunophenotyping of 540 consecutive patients with B-cell chronic lymphocytic leukemia, Blood, 78, 1795-1802.
19. Kurec, A. S., Threatte, A. J., Gottlieb, A. J., Smith, J. R., Anderson, J and Davey, F. R. (1992) Immunophenotypic subclassification of chronic lymphocytic leukaemia (CLL), British Journal of Haematology, 81, 45-51.
20. Witzig, T. E., Li, C. Y., Tefferi A. and Katzmann, J. A. (1994) Measurement of the intensity of cell surface antigen expression in B-cell chronic lymphocytic leukemia, American Journal of Clinical Pathology, 101, 312-7.
21. Mandy, F. F., Bergeron, M., Recktenwald, D. and Izaguirre, C. A. (1992) A simultaneous three-color T cell subsets analysis with single laser flow cytometers using T cell gating protocol, Journal of Immunological Methods, 156, 151-62.
22. Rai, K., Sawitsky, A., Cronkite, E P., Chanana, A. D. Levy and R. N. Pasternack, B. S. (1975) Clinical staging of chronic lymphocytic leukemia. Blood, 46, 219-34.
23. Jakšić, B. and Vitale, B. (1981) Total tumour mass score (TTM): A new parameter in chronic lymphocytic leukemia, British Journal of Haematology, 49, 405-13.
24. Rabatić, S., Gagro, A. and Medar-Lasić, M. (1993) CD21-CD23 ligand pair expression in children with allergic asthma. Clinical Experimental Immunology, 94, 337-40.
25. Mažuran, R., Sabioncello, A., Rabatić, S., Svoboda-Beusan, I., Ikić-Sutlić, M., Broketa, G., Silobrčič, V. and Dekans, D. (1991) Laboratory testing in clinical immunology. 1. Characteristics and critical comments, Periodicum Biologorum, 93, 111-7.
26. Tefferi, A., Li, C. Y and Phyliky, R. (1988) Role of immunophenotyping in chronic lymphocytosis: Review of the natural history of the condition in 145 adult patients, Mayo Clinic Proceedings, 63, 801-6.
27. Hannet, I., Erkeller-Yuksel, F., Deneys, V., Lydyard, P. and De Bruyere, M. (1992) Developmental and maturational changes in human blood lymphocyte subpopulations, Immunology Today, 13, 215-8.
28. Waldschmidt, T. J., Kroese, F. G., Tygrett, L. T., Conrad, D. H and Lynch, R. G. (1991) The expression of B cell surface receptors. III The murine low-affinity IgE Fc receptor is not expressed on Ly 1 or "Ly 1-like" B cells, International Immunology, 3, 305-15.
29. Delespesse, G., Sarfati, M., Wu, C. Y., Fournier, S. and Letellier, M (1992) The low-affinity receptor for IgE, Immunological Reviews, 125, 78-97.
30. Fournier, S., Rubio, M., Delespesse, G. and Sarfati, M. (1994) Role for low-affinity receptor for IgE (CD23) in normal and leukemic B-cell proliferation. Blood, 84, 1881-6.
31. Tooze, J. A. and Bevan, D. H (1991) Decreased expression of complement receptor type 2 (CR2) on neoplastic B cells of chronic lymphocytic leukaemia. Clinical Experimental Immunology, 83, 423-9.
32. Tooze, J. A., Bevan, D. H. and Lever, A. M. L. (1992) Surface and molecular expression of complement-receptor type 2 of neoplastic CD5+ B cells in chronic lymphocytic leukemia, Annals of the New York Academy of Sciences, 651, 494-7.
33. Faeron, D. T (1993) The CD19-CR2-TAPA-1 complex. CD45 and signalling by the antigen receptor of B lymphocytes. Current Opinion in Immunology, 5, 341-8.